PET/CT helps predict survival in patients with breast cancer

03/11/2012 | MolecularImaging.net

Changes in 18F-FDG PET/CT standard uptake value measured before and again three months after selective internal radiation therapy can help predict survival in patients who have hepatic metastases due to breast cancer, according to a study in the Journal of Nuclear Medicine. Patients who responded to radioembolization survived longer than those who didn't, the study found.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC